An equity research analyst for Bloomberg Intelligence, calculated that Pfizer and BioNTech could expect $24 billion of revenues. That would equate to $7 billion in profit for each company.
Moderna,charges somewhere between $25 and $37 per dose, and could add almost $30 billion to its revenues, according to market analysts.
|Member Since||15 Sep 2011|
|Member Since||5 May 2012|
|Member Since||16 Jun 2013|